Nature Communications Reveals Alpibectir`s Unique Action
13 Apr 2026 //
GLOBENEWSWIRE
BioVersys Doses First Patient in Phase 2b AlpE Pulmonary TB Trial
13 Mar 2026 //
GLOBENEWSWIRE
BioVersys Granted EMA Orphan Status for Alpibectir & Ethionamide
27 Aug 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support